Member Sign In
Member Sign Out
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Already have an account?
Sign in using your social networking account:
Sign in using your social networking
Forgot your password?
Akadeum looks to advance the cell separation process with microbubbles
Microbubble technology offers researchers the ability to perform cell separation without a column or magnet, generating higher yield and faster turnaround times, according to Akadeum Life Sciences CEO Brandon McNaughton who spoke with
about the company's technology.
Stanford platform improves hunt for antigens that trigger strong immune responses
Researchers at Stanford University have developed a method for making faster, more accurate predictions of which antigens will trigger a strong immune response. Their work could help scientists develop more effective cancer immunotherapies.
Imaging technique reveals previously unseen nanostructures in brain tissue
Swellable hydrogels have enabled researchers to “decrowd” biomolecular structures in cells and tissues, revealing previously hidden nanostructures and providing imaging of the structure of Alzheimer’s-linked amyloid beta plaques in greater detail than has been possible before.
Oncolytic virotherapy, immunotherapy combo shows promise for treatment-resistant cancers
A combination of oncolytic virotherapy, a technique using cancer-fighting viruses, acting in concert with immunotherapy shows promise for treatment-resistant cancers, according to new research.
CRISPR reveals way to enhance the function, persistence of CAR T-cell therapies
The use of CRISPR knockout screens have uncovered a new regulator of immunity that could enhance the function and persistence of anticancer T-cell therapies, according to a study published on August 24 in the journal
Biomolecular condensates could transform drug discovery, says Dewpoint Therapeutics
Boston-based biotech company Dewpoint Therapeutics contends there are untapped opportunities for targeting biomolecular condensates to develop therapeutic agents for a wide array of diseases, potentially transforming the drug discovery process.
Antiviral-antibody combination improves influenza outcomes in mice
Researchers at McMaster University found in a mouse study that combining a class of well-known antiviral drugs and neutralizing antibodies was more effective than either approach alone, which they contend could be used to treat seasonal influenza and help prevent the next flu pandemic.
Blood-brain barrier cells regulate neurons in fruit flies, suggesting role in neurodegeneration
Cells in the blood-brain barrier regulate nerve ensheathment and neurotransmitter release in fruit flies, suggesting they may play a role in neurological conditions in humans.
Synthesis breakthrough opens door to development of natural product as cancer therapy
Princeton University scientists have halved the number of steps needed to synthesize pleurotin, setting the stage for work to realize the anticancer and antibiotic potential of the molecule.
Repurposed drug shows promise in animal studies as potential therapy for ALS
A drug used to treat enlarged prostates and high blood pressure could help to slow the progression of motor neuron disease, which is also known as amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder.
More Conferences »»
Newly-discovered organelle key to sense of smell
Immune surprise: alarm protein drives inflammation
Study: Menarini’s CellSearch technology effective in measuring and monitoring CTC levels in multiple myeloma
Oxytocin could be the key to neural plasticity: study
NIH awards $1.8M grant to study long-term memory
More articles »
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard